Two Zeneca Defenses Nixed In $275M Chancery Drug Dispute
Zeneca Inc. on Friday lost two of 10 affirmative defenses claimed in a Chancery Court battle over $275 million in cancer drug trial "milestone" payments sought by a merger partner, with...To view the full article, register now.
Already a subscriber? Click here to view full article